Voluntary Voluntary Smallpox Vaccination Urged
Offer to General Population Represents a Shift
in Policy
Julie L.
Gerberding, director of the Centers of Disease Control, says, "Right
now, our thinking is in favor of making vaccine available to the
general public." (Erik S. Lesser - AP)
_____ More on Smallpox_____
•
New Set of Potential Risks (The Washington Post, Oct
5, 2002)
•
Md. Considers Smallpox Response Team (The Washington
Post, Sep 27, 2002)
•
Volunteers Key to Smallpox Vaccine Plan (The
Washington Post, Sep 24, 2002)
•
Smallpox Vaccine Guidelines Readied (The Washington
Post, Sep 23, 2002)
•
Maker of Smallpox Vaccine Cites Progress (The
Washington Post, Sep 19, 2002)
•
Smallpox Vaccination for Medical Workers Proposed
(The Washington Post, Sep 4, 2002)
Find Post
Stories by Topic:
--or--
Search Story
Archive by Keyword:
Advanced Search
By a Washington Post Staff Writer
Saturday, October 5, 2002; Page A01
The Bush administration's top bioterrorism advisers said yesterday they
support a voluntary smallpox vaccination program that would begin with
500,000 health care workers, expand to 10 million emergency responders and
extend to the rest of the population as early as 2004.
It was the first time high-ranking administration officials acknowledged
they are considering offering the risky vaccine to the public prior to an
attack and it represented a profound shift in thinking from the June
recommendations of a government advisory panel to inoculate about 20,000
medical personnel.
"We live in a society that values individual choice," said Julie L.
Gerberding, director of the Centers for Disease Control and Prevention. "If
we have vaccine and we have data to accurately assess the safety, one school
of thought is that informed people may want to have the choice of getting
vaccine or not."
In a 90-minute briefing at the Department of Health and Human Services,
the group of officials responsible for implementing a bioterror response
plan laid out the options before President Bush, stressing that he has yet
to make a decision on who could be vaccinated and when. If a smallpox case
were detected, officials would assume the nation was under attack and would
quickly move to nationwide vaccination.
Developing a "pre-attack" vaccination policy, however, has proven to be
"extremely difficult" because of the challenge in balancing the possible
risks of the vaccine against the risks of an attack, said Jerome M. Hauer,
assistant secretary for emergency health preparedness.
Although they have no way of knowing the likelihood of a smallpox attack,
health experts fear such an attack because the virus is so contagious and so
deadly. About one-third of people who get the disease die, yet the vaccine
itself can cause serious, sometimes fatal, complications.
Concerns that Iraq or another hostile nation may have acquired the virus
have added urgency to the vaccination debate. "We need to be mindful that
the context of this decision has changed a bit" since the far more
conservative June recommendations, Gerberding said.
Vice President Cheney has speculated that the threat from Iraqi President
Saddam Hussein may necessitate mass vaccination. Privately, sources said
Cheney has vigorously advocated a broad vaccination policy. White House
spokesman Scott McClellan said last night the policy "is under review" but
he could not elaborate on a timetable or factors involved in the decision.
Since last fall's anthrax attacks, federal health officials have moved
swiftly to build up the nation's smallpox vaccine stockpile. If an attack
occurred today, they said they could safely dilute the existing supply to
inoculate every American. By the end of next year, they expect to have 209
million doses of new vaccine on hand. None of the vaccine has been licensed
by the Food and Drug Administration, but officials expect the first batches
will be approved by November.
At the request of the Department of Defense, Hauer said HHS will provide
the first 1 million doses of licensed smallpox vaccine to the military
within the month. Pentagon spokesman James Turner refused to comment.
For civilians, the HHS team favors a policy of "ever-expanding access to
vaccine" that could be phased in as more vaccine is licensed and scientists
have time to monitor early reactions to it. Using licensed vaccine would be
much easier logistically than administering it as an experimental treatment
that involves tricky liability issues.
The approach envisions vaccinating the people considered to be at
greatest risk if an outbreak occurs. That would include public health
investigators, emergency room workers and even janitors and security guards
at local hospitals.
The goal in the early stages, Gerberding said, "is to maximize our
ability to respond to an attack should one occur."
In the second phase, as many as 7.5 million medical workers would be
offered vaccine, along with the nation's 3 million firefighters, police
officers and rescue workers, Hauer said. Inoculating that many emergency
personnel "would make it even easier to respond" to an attack, Gerberding
explained. It is possible Bush would combine the first two phases and opt to
inoculate the majority of first responders immediately.
At some later date, perhaps in early 2004, vaccine could be offered to
every American. "Right now, our thinking is in favor of making vaccine
available to the general public," Gerberding said.
Federal health officials rejected the advice of its advisory panel to
designate certain smallpox hospitals because Hauer said it was unrealistic
to think patients would follow those guidelines.
America stopped routine vaccination in 1972, which means about 45 percent
of the population has never been inoculated. It is unclear how much immunity
remains from vaccines given 30 or 40 years ago.
Between 30 million and 50 million Americans should not be given the
vaccine because they have weak immune systems, said Anthony S. Fauci,
director of the National Institute of Allergy and Infectious Diseases. That
includes people who have received chemotherapy, have eczema or are infected
with the AIDS virus. For every 1 million vaccinated, 15 people are likely to
suffer life-threatening complications and one or two would die.
Because there is limited scientific data, it is difficult to predict the
risks of a person spreading the virus in the vaccine to others.
Administration aides are still grappling with the liability issues of
reviving a vaccination program.
State health officials have until Dec. 1 to file plans for mass
vaccination within five to 10 days of an attack, Hauer said. In the event of
an attack, he observed, "Five days might be a luxury."
© 2002 The Washington Post Company
Related Links
Full Coverage
More Health News
More National News
Latest Business News
Dulles to Get Federal Screeners Today
(The Washington Post, 10/8/02)
The $25 Million Question: Why Not More?
(The Washington Post, 10/8/02)
Stopped at the State Line
(The Washington Post, 10/8/02)
Business
Section
Technology Section
Full Coverage
More Science
News